Palo Alto, CA – According to filings with the U.S. Securities and Exchange Commission, Glooko is raising $35,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Russ Johannesson played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Glooko

Glooko is transforming digital health by connecting people with chronic conditions like diabetes and obesity and their healthcare professionals, enabling telehealth, clinical research, and improved collaboration. The company’s software platforms empower diabetes and obesity management by collecting and unlocking the power of data from blood-glucose meters, CGMs, insulin pumps, pens, wearables, weight management devices, blood pressure technology and activity trackers bringing insights together in one place. Data is easily uploaded remotely via app or in-clinic, securely shared, and visualized in actionable charts and graphs. This creates a solid foundation enabling collaboration and confident treatment decisions. The platforms are compatible with the vast majority of diabetes devices available, giving people with diabetes and obesity and their care teams the freedom of choice. Over 3 million users have benefited from data insights using Glooko’s solutions, which are trusted by world leaders in health care, and used in 27 countries across 20 languages. Their US headquarters are located in Palo Alto, CA with European headquarters in Gothenburg, Sweden.

To learn more about Glooko, visit http://www.glooko.com/

Contact:
Russ Johannesson, Chief Executive Officer
650-720-5310
russ@glooko.com
https://www.linkedin.com/in/russjohannesson/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved